A Critical Role of Luteolin-Induced Reactive Oxygen Species in Blockage of Tumor Necrosis Factor-Activated Nuclear Factor-κB Pathway and Sensitization of Apoptosis in Lung Cancer Cells
暂无分享,去创建一个
S. Belinsky | Wenshu Chen | Honglian Shi | Y. Lin | Xia Wang | Wei Ju
[1] N. Fausto,et al. Impaired Preneoplastic Changes and Liver Tumor Formation in Tumor Necrosis Factor Receptor Type 1 Knockout Mice , 2000, The Journal of experimental medicine.
[2] S. Pervaiz,et al. TNF receptor superfamily‐induced cell death: redox‐dependent execution , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[3] Y. Lin,et al. Cleavage of the death domain kinase RIP by caspase-8 prompts TNF-induced apoptosis. , 1999, Genes & development.
[4] Zheng‐gang Liu,et al. The Essential Role of the Death Domain Kinase Receptor-interacting Protein in Insulin Growth Factor-I-induced c-Jun N-terminal Kinase Activation* , 2006, Journal of Biological Chemistry.
[5] Michael Karin,et al. The IKK NF-kappa B system: a treasure trove for drug development. , 2004, Nature reviews. Drug discovery.
[6] J. Ross,et al. Dietary flavonoids: bioavailability, metabolic effects, and safety. , 2002, Annual review of nutrition.
[7] E. Zandi,et al. Iron-mediated H2O2 Production as a Mechanism for Cell Type-specific Inhibition of Tumor Necrosis Factor α-Induced but Not Interleukin-1β-induced IκB Kinase Complex/Nuclear Factor-κB Activation* , 2005, Journal of Biological Chemistry.
[8] J. Rüschoff,et al. Enhancement of experimental metastasis by tumor necrosis factor , 1993, The Journal of experimental medicine.
[9] G. Kollias,et al. Mice deficient in tumor necrosis factor-alpha are resistant to skin carcinogenesis. , 1999, Nature medicine.
[10] A. Lin,et al. Role of JNK activation in apoptosis: A double-edged sword , 2005, Cell Research.
[11] A. Lin,et al. The true face of JNK activation in apoptosis , 2002, Aging cell.
[12] Takahiro Doi,et al. NF‐κB inhibits TNF‐induced accumulation of ROS that mediate prolonged MAPK activation and necrotic cell death , 2003, The EMBO journal.
[13] S. Belinsky,et al. 17-allylamino-17-demethoxygeldanamycin synergistically potentiates tumor necrosis factor-induced lung cancer cell death by blocking the nuclear factor-kappaB pathway. , 2006, Cancer research.
[14] C. Kandaswami,et al. The antitumor activities of flavonoids. , 2005, In vivo.
[15] W. Shea-Eaton,et al. TNFalpha induces NFkappaB/p50 in association with the growth and morphogenesis of normal and transformed rat mammary epithelial cells. , 2001, Journal of cellular physiology.
[16] R. Casareno,et al. The Copper Chaperone for Superoxide Dismutase* , 1997, The Journal of Biological Chemistry.
[17] D. Haller,et al. Functional diversity of flavonoids in the inhibition of the proinflammatory NF-kappaB, IRF, and Akt signaling pathways in murine intestinal epithelial cells. , 2006, The Journal of nutrition.
[18] W. Liao,et al. The essential role of MEKK3 in TNF-induced NF-κB activation , 2001, Nature Immunology.
[19] M. Kelliher,et al. The distinct roles of TRAF2 and RIP in IKK activation by TNF-R1: TRAF2 recruits IKK to TNF-R1 while RIP mediates IKK activation. , 2000, Immunity.
[20] T. Cotter,et al. Regulation and measurement of oxidative stress in apoptosis. , 2002, Journal of immunological methods.
[21] T. Kaneko,et al. Cytotoxicity of flavonoids toward cultured normal human cells. , 2005, Biological & pharmaceutical bulletin.
[22] L. Morbidelli,et al. Luteolin Inhibits Vascular Endothelial Growth Factor-Induced Angiogenesis; Inhibition of Endothelial Cell Survival and Proliferation by Targeting Phosphatidylinositol 3′-Kinase Activity , 2004, Cancer Research.
[23] B. Aggarwal. Signalling pathways of the TNF superfamily: a double-edged sword , 2003, Nature Reviews Immunology.
[24] M. Karin,et al. Inhibition of NF-kappaB in cancer cells converts inflammation- induced tumor growth mediated by TNFalpha to TRAIL-mediated tumor regression. , 2004, Cancer cell.
[25] Fei Chen,et al. Reactive oxygen species (ROS), troublemakers between nuclear factor-kappaB (NF-kappaB) and c-Jun NH(2)-terminal kinase (JNK). , 2004, Cancer research.
[26] S. Ryu,et al. Luteolin inhibits the nuclear factor-κB transcriptional activity in Rat-1 fibroblasts , 2003 .
[27] Sun-Hee Kim,et al. Luteolin inhibits the nuclear factor-kappa B transcriptional activity in Rat-1 fibroblasts. , 2003, Biochemical pharmacology.
[28] D. Bar-Sagi,et al. Redox-dependent downregulation of Rho by Rac , 2003, Nature Cell Biology.
[29] G. Kollias,et al. Mice deficient in tumor necrosis factor-α are resistant to skin carcinogenesis , 1999, Nature Medicine.
[30] S. Nedospasov,et al. Tumor Necrosis Factor-induced Nonapoptotic Cell Death Requires Receptor-interacting Protein-mediated Cellular Reactive Oxygen Species Accumulation* , 2004, Journal of Biological Chemistry.
[31] C. Ong,et al. Luteolin sensitizes tumor necrosis factor-α-induced apoptosis in human tumor cells , 2004, Oncogene.
[32] R. Radcliffe,et al. Tnfa and Il‐10 deficiencies have contrasting effects on lung tumor susceptibility: Gender‐dependent modulation of IL‐10 haploinsufficiency , 2003, Molecular carcinogenesis.
[33] H. Ueda,et al. Luteolin as an anti-inflammatory and anti-allergic constituent of Perilla frutescens. , 2002, Biological & pharmaceutical bulletin.
[34] Michael Karin,et al. Reactive Oxygen Species Promote TNFα-Induced Death and Sustained JNK Activation by Inhibiting MAP Kinase Phosphatases , 2005, Cell.
[35] C. Ong,et al. Luteolin sensitizes tumor necrosis factor-alpha-induced apoptosis in human tumor cells. , 2004, Oncogene.
[36] P. Scheurich,et al. Tumor necrosis factor signaling , 2003, Cell Death and Differentiation.
[37] S. Rhee. Cell signaling. H2O2, a necessary evil for cell signaling. , 2006, Science.
[38] R. Flavell,et al. JNK potentiates TNF-stimulated necrosis by increasing the production of cytotoxic reactive oxygen species. , 2004, Genes & development.
[39] Hong-Zin Lee,et al. Luteolin induced DNA damage leading to human lung squamous carcinoma CH27 cell apoptosis. , 2005, European journal of pharmacology.
[40] W. Liao,et al. The essential role of MEKK3 in TNF-induced NF-kappaB activation. , 2001, Nature immunology.
[41] M. Karin,et al. Inhibition of NF-κB in cancer cells converts inflammation- induced tumor growth mediated by TNFα to TRAIL-mediated tumor regression , 2004 .
[42] K. Kataoka,et al. Spatial Redox Regulation of a Critical Cysteine Residue of NF-κB in Vivo * , 2002, The Journal of Biological Chemistry.
[43] C. Skibola,et al. Guest Editors: Enrique Cadenas and Kelvin J. A. Davies POTENTIAL HEALTH IMPACTS OF EXCESSIVE FLAVONOID INTAKE , 2000 .
[44] S. Rhee,et al. H2O2, a Necessary Evil for Cell Signaling , 2006, Science.
[45] Fei Chen,et al. Reactive Oxygen Species (ROS), Troublemakers between Nuclear Factor-κB (NF-κB) and c-Jun NH2-terminal Kinase (JNK) , 2004, Cancer Research.
[46] Hongtao Zhao,et al. Detection and characterization of the product of hydroethidine and intracellular superoxide by HPLC and limitations of fluorescence. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[47] C. Roussos,et al. Luteolin inhibits an endotoxin-stimulated phosphorylation cascade and proinflammatory cytokine production in macrophages. , 2001, The Journal of pharmacology and experimental therapeutics.